CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-21 | ADAMS JULIAN Director | Grant or award · Stock Option (Right to Buy) | +4,100 | 4,100 | ||
| 2024-11-21 | Ashe Carol Gail Director | Grant or award · Stock Option (Right to Buy) | +4,100 | 4,100 | ||
| 2024-11-21 | Venkatesan Jay Director | Grant or award · Stock Option (Right to Buy) | +4,100 | 4,100 | ||
| 2024-11-21 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +4,100 | 4,100 | ||
| 2024-11-21 | Chudnovsky Yekaterina Director | Grant or award · Stock Option (Right to Buy) | +4,100 | 4,100 | ||
| 2024-11-21 | Nissenson Allen Director | Grant or award · Stock Option (Right to Buy) | +4,100 | 4,100 | ||
| 2024-09-30 | Connelly Robert CEO, President and Director | Grant or award · Stock Option (Right to Buy) | +91,600 | 91,600 | ||
| 2024-09-30 | DeMuth Peter Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +29,800 | 29,800 | ||
| 2024-09-30 | Haqq Christopher See Remarks | Grant or award · Stock Option (Right to Buy) | +28,200 | 28,200 | ||
| 2024-08-12 | Chudnovsky Yekaterina Director | Purchase · Convertible Note (convertible into Common Stock) | +3,442,341 | $5.81 | $20.0M | 3,442,341 |
| 2024-06-28 | Venkatesan Jay Director | Purchase · Common Warrants | +50,000 | 50,000 | ||
| 2024-06-28 | Venkatesan Jay Director | Purchase · Pre-Funded Warrants | +50,000 | $4.99 | $250K | 50,000 |
| 2024-06-28 | Venkatesan Jay Director | Purchase · Common Warrants | +50,000 | 50,000 | ||
| 2024-06-28 | Venkatesan Jay Director | Purchase · Pre-Funded Warrants | +50,000 | $4.99 | $250K | 50,000 |
| 2024-06-28 | Venkatesan Jay Director | Purchase · Common Warrants | +50,000 | 50,000 | ||
| 2024-06-28 | Venkatesan Jay Director | Purchase · Pre-Funded Warrants | +50,000 | $4.99 | $250K | 50,000 |
| 2024-06-28 | Venkatesan Jay Director | Purchase · Common Warrants | +50,000 | 50,000 | ||
| 2024-06-28 | Venkatesan Jay Director | Purchase · Pre-Funded Warrants | +50,000 | $4.99 | $250K | 50,000 |
| 2024-06-28 | Venkatesan Jay Director | Purchase · Common Warrants | +50,000 | 50,000 | ||
| 2024-06-28 | Venkatesan Jay Director | Purchase · Pre-Funded Warrants | +50,000 | $4.99 | $250K | 50,000 |
Page 3 of 9 · 171 trades